The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 01, 2024

Filed:

Oct. 26, 2022
Applicant:

Southern Research Institute, Birmingham, AL (US);

Inventors:

Omar Moukha-Chafiq, Hoover, AL (US);

Corinne Elizabeth Augelli-Szafran, Homewood, AL (US);

Rebecca Boohaker, Birmingham, AL (US);

Larry D. Bratton, Birmingham, AL (US);

Marina Fosso Yatchang, Chelsea, AL (US);

Anish K. Vadukoot, Nashville, TN (US);

Assignee:

Southern Research Institute, Birmingham, AL (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07H 19/16 (2006.01); A61P 35/00 (2006.01); C07H 19/20 (2006.01);
U.S. Cl.
CPC ...
C07H 19/16 (2013.01); A61P 35/00 (2018.01); C07H 19/20 (2013.01);
Abstract

The present disclosure is concerned with Clofarabine analogs for the treatment of various cancers such as, for example, sarcomas, carcinomas, hematological cancers, solid tumors, breast cancer, cervical cancer, gastrointestinal cancer, colorectal cancer, brain cancer, skin cancer, prostate cancer, ovarian cancer, bladder cancer, thyroid cancer, testicular cancer, pancreatic cancer, endometrial cancer, melanomas, gliomas, leukemias, lymphomas, chronic myeloproliferative disorders, myelodysplastic syndromes, myeloproliferative neoplasms, and plasma cell neoplasms (myelomas). This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.


Find Patent Forward Citations

Loading…